- Filed
- Feb 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 21, 2025 | 20.42M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $31.99M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $48.01M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $63.91M |
| Current Assets | FY 2024 · Dec 31, 2023 | $63.89M |
| Total Assets | FY 2024 · Dec 31, 2023 | $227.68M |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 19.99M sh |
| Dividends Paid | FY 2024 · Dec 31, 2022 | $25.01M |
| Capex | FY 2024 · Dec 31, 2022 | $3.78M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $6.46M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $1.09 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $1.11 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $37.8M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $13.63M |
| Net Income | FY 2024 · Dec 31, 2022 | $21.86M |
| Operating Income | FY 2024 · Dec 31, 2022 | $238K |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $28.27M |
| Revenue | FY 2024 · Dec 31, 2022 | $134.53M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2021 | $172.71M |